Mexico Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Mexico Pharmaceuticals and Healthcare Report Q4 2013 Aug 7th 2013, 00:00, by rnrmahesh BMI View: Under the Pacific Alliance agreement, Chile, Peru and Colombia will recognise medicine registrations issued by COFEPRlS and allow easy entry to pharmaceutical products approved by the organisation. Mexico’s well-recognised drug approval standard among Latin American countries should encourage multinationals to launch more products in the country and pave the way for an integrated pharmaceutical market among Pacific Alliance member states. Multinationals and Mexican drugmakers will enjoy faster access to markets in the member states, and local consumers will immediately have higher quality and potentially lower priced medicines available. Headline Expenditure Projections ? Pharmaceuticals: MXN176.00bn (US$13.38bn) in 2012 to … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=110349. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/mexico-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions